메뉴 건너뛰기




Volumn 122, Issue 18, 2000, Pages 4304-4309

Stereoselective glycosylations of a family of 6-deoxy-1,2-glycals generated by catalytic alkynol cycloisomerization

Author keywords

[No Author keywords available]

Indexed keywords

6 DEOXY 1,2 GLYCAL DERIVATIVE; DEXTRO DIGITOXOSE BETA 4 DEXTRO DIGITOXOSE GLYCAL; GLYCOSIDE; IODOACETIC ACID; OLIGOSACCHARIDE; TUNGSTEN DERIVATIVE; UNCLASSIFIED DRUG;

EID: 0034630891     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja994229u     Document Type: Article
Times cited : (189)

References (45)
  • 2
    • 33748993918 scopus 로고
    • Cardiac Glycosides, Part 1: Experimental Pharmacology
    • Cardiac Glycosides, Part 1: Experimental Pharmacology. In Handbook Exp. Pharmacol. 1981, vol. 56.
    • (1981) Handbook Exp. Pharmacol. , vol.56
  • 23
    • 0343380742 scopus 로고    scopus 로고
    • note
    • 3 is not required for the removal of alkynylsilanes from our substrates.
  • 25
    • 0342945281 scopus 로고    scopus 로고
    • note
    • D = +53.9) obtained in two steps from 3,4-di-O-acetyl-L-rhamnal: (a) NaOMe, MeOH; (b) TBDMSCl, imidazole, DMF. This also establishes the absolute configuration of all glycals 10-13 and confirms absolute and relative stereoinduction in the preparation of epoxyalkynol 2.
  • 26
    • 0343380741 scopus 로고    scopus 로고
    • note
    • Cycloisomerizations of substrates 6 and 7 (leading to glycals ribo-10 and lyxo-11) are facile and proceed in nearly quantitative yields, whereas the cyclization of 8a/b to arabino-glycals 12a/b is slightly slower. Substrates 9a/b leading to xylo-glycals 13a/b proceed in satisfactory yield but in all cases approximately 10% of exo-cyclization product is formed along with the major endo-cyclization products 13a/b.
  • 29
    • 0342945280 scopus 로고    scopus 로고
    • Prepared from 4 in 83% yield: TBDMSCl (1.0 equiv), imidazole (2.0 equiv). DMF
    • Prepared from 4 in 83% yield: TBDMSCl (1.0 equiv), imidazole (2.0 equiv). DMF.
  • 36
    • 0033598270 scopus 로고    scopus 로고
    • For representative direct iodoglycosylations, see
    • (c) Roush, W. R.; Narayan, S. Org. Lett. 1999, 1, 899. For representative direct iodoglycosylations, see:
    • (1999) Org. Lett. , vol.1 , pp. 899
    • Roush, W.R.1    Narayan, S.2
  • 43
    • 0342945278 scopus 로고    scopus 로고
    • note
    • The use of TMSOTf gave slightly lower yields of glycosylation products along with byproduct arising from loss of the TBDMS protective group.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.